Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

558.52
-45.0600-7.47%
Post-market: 559.851.33+0.24%19:57 EDT
Volume:1.51M
Turnover:861.10M
Market Cap:60.32B
PE:14.17
High:606.87
Open:601.01
Low:557.64
Close:603.58
Loading ...

FACTBOX-How companies are responding to Trump's tariffs

Reuters
·
22 Apr

Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for

Zacks
·
22 Apr

Regeneron Pharma Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
22 Apr

Canaccord Genuity Adjusts Price Target on Regeneron Pharmaceuticals to $850 From $1,152, Maintains Buy Rating

MT Newswires Live
·
22 Apr

Regeneron Pharma Coverage Assumed by Cantor Fitzgerald at Overweight

Dow Jones
·
22 Apr

Regeneron Partners With Fujifilm to Expand Manufacturing Capacity

Dow Jones
·
22 Apr

Regeneron to invest over $3 billion to boost US manufacturing

Reuters
·
22 Apr

Regeneron to Expand US Biologics Production Through $3 Billion Fujifilm Deal

MT Newswires Live
·
22 Apr

Regeneron signs over $3 billion deal with contract drugmaker to boost US manufacturing

Reuters
·
22 Apr

Regeneron expands manufacturing capacity through new agreement with Fujifilm

TIPRANKS
·
22 Apr

BRIEF-Fujifilm Diosynth Biotechnologies And Regeneron Sign 10-Year U.S. Manufacturing Agreement

Reuters
·
22 Apr

BRIEF-Regeneron Announces New Investment In Manufacturing Of Its Biologic Medicines

Reuters
·
22 Apr

Fujifilm Diosynth Biotechnologies and Regeneron Sign a 10-Year U.S. Manufacturing Agreement Valued at Over $3 Billion

THOMSON REUTERS
·
22 Apr

Regeneron Pharmaceuticals - Ongoing & Planned Investments in NY and Nc to Total Over $7 Billion

THOMSON REUTERS
·
22 Apr

Regeneron Announces New Investment in Manufacturing of Its Industry-Leading Biologic Medicines

THOMSON REUTERS
·
22 Apr

Regeneron Pharmaceuticals - Total Investment in Fujifilm Diosynth Biotechnologies Agreement Estimated to Exceed $3 Billion

THOMSON REUTERS
·
22 Apr

Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines

GlobeNewswire
·
22 Apr

Regeneron assumed at Overweight from Neutral at Cantor Fitzgerald

TIPRANKS
·
22 Apr

Regeneron Announces Investor Conference Presentations

GlobeNewswire
·
22 Apr

Wolfe Research Adjusts Regeneron Pharmaceuticals PT to $950 From $1,000, Keeps Outperform Rating

MT Newswires Live
·
21 Apr